Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

Neptune Technologies & Bioressources Inc T.NTB

Sector: Healthcare | Sub-Sector: Biotechnology

Neptune Technologies & Bioressources Inc is a biotechnology company engaged in the development, manufacture and commercialization of marine-derived omega-3 polyunsaturated fatty acids.
Price: $2.32 | Change: $-0.02 | %Change: -0.85%
Volume: 48,220 | Day High/Low: 2.36/2.32 | 52 Week High/Low: 3.60/1.26
View modes: 
3 stars

RE:RE:Who is officially running Acasti?

with a new senior manager coming in, investors were hoping for clear directions and better communication. But the ship is still drifting and absolutely no communication. Yes, they do have an excellent...read more
5 stars

RE:Who is officially running Acasti?

Yes, it hasn't been clear since Waksal left that they have their stuff together, unfortunately.  They have a good drug, not sure why instilling a little confidence is so hard for them to do.  rate and reply
3 stars

RE:Who is officially running Acasti?

Hopefully, one day the "new CEO" will come out of........, and tell the investors what is what and who is who, also to a presentation of his priorities and in what direction he is going to take the...read more
3 stars

Who is officially running Acasti?

At least Acasti should say who is in charge.  I thought that Jim Hamilton was going to take the responsibility, but so far no such announcement. Are they looking for the CEO or what? Who in Acasti is...read more
0 stars

RE:Acasti Pharma Gains Ahead Of Expected Phase II Results

Obviously there's some confusion as to what is going to be said/done. The market seems to believe that there will be a news release regarding the full blown results by the end of February. I've been...read more
0 stars

Acasti Pharma Gains Ahead Of Expected Phase II Results

http://finance.yahoo.com/news/acasti-pharma-gains-ahead-expected-192451696.html  rate and reply
0 stars

RE:RE:Acasti is moving upward today with a good volume so far.

Acasti's move is because of Amarin's sp rise recently. Today they announced that they will be selling Vascepa in China. The  more successful Amarin is the better will be for Acasti as it has a...read more
0 stars

RE:Acasti is moving upward today with a good volume so far.

Very interesting....  rate and reply
0 stars

Acasti is moving upward today with a good volume so far.

I hope that this means some postive thing is up on Acasti's side.  rate and reply
0 stars

RE:Q4 revenue

Doesn't LeBel run the plant? He probably sold the shares because he needed the money. An insider who sells shares hurts himself more than anyone else, because he/she is more heavilty invested in the...read more
3 stars

RE:Q4 revenue

you are absolutely right. Investors need no daytraders on the management team. The one you forgot is our "new CEO", who has been on the job for 4 weeks, absent from the shareholders (who own the...read more
3 stars

Q4 revenue

According to Neptune, the customer waited for the Neptune's product purchased in Q3.   Q4 revenue is very important since it would show if Neptune can sustain the growth.  I hope that Neptune can...read more
5 stars

RE:Acasti

I could be wrong, but I don't think management plans on releasing Acasti's full results by end of Feb - I think they (i.e. management) expect to receive the full results (who know from where!) - see...read more
3 stars

Acasti

Weren't they suppose to announce results in Feb? Time is a running.  rate and reply
0 stars

Chart.

I'm kind of liking the way Neptune's chart is looking over the past 5 months.  Very reminiscent of the end of 2010/ beginning of 2011.  rate and reply
0 stars

NeuroBioPharm Receives Final Court Approval...

NeuroBioPharm Receives Final Court Approval and Completes Arrangement With Neptune http://finance.yahoo.com/news/neurobiopharm-receives-final-court-approval-123000072.html  rate and reply
0 stars

RE:Acasti moving back up

Sean, Hamilton indicated that the pharma side of krill is where the multinationals would be looking to. Acasti at this price is a no-brainer.  rate and reply
0 stars

Acasti moving back up

Acasti continues to move higher.. We should be hearing about P3 soon. Amarin has also been rising recently as their Rx numbers are rising and they are getting more attention. This bodes very well for...read more
0 stars

RE:RE:RE:the insiders just keep on selling...

wow, an insider BOUGHT 10,800 shares Canadian Insider  rate and reply
5 stars

interesting

http://www.nutraingredients-usa.com/Suppliers2/Neptune-s-new-CEO-Science-will-drive-the-next-wave-of-change-in-the-omega-3-market  rate and reply